Protective Effects of Dioscin and Diosgenin on Plateau Hyperuricemia by Attenuating Renal Inflammation via EPHX2
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413399 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Wanyun Dang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Hyperuricemia, Diosgenin, Kidney, Epoxide Hydrolases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: yue Gao, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Plateau hyperuricemia is a common disease in the plateau area, and the incidence is much higher than that in the plain area. Dioscin (DIO) and its active metabolite Diosgenin (DG) exert therapeutic effects on hyperuricemia through oxidative stress and inflammation. In this study, DIO and its active metabolite DG were taken as the research objects to explore their therapeutic effects on high-altitude hyperuricemia in rats. To evaluate the therapeutic effect of DIO on the rat model of high-altitude hyperuricemia, the evaluation indexes include blood biochemical indexes, renal histopathology, oil red O staining of the kidney, rat kidney index, and rat renal inflammatory factors. Transcriptomics was used to analyze the control group, model group, and drug-administered group to preliminarily explore the protective mechanism of DIO in rats with high-altitude hyperuricemia. An HK-2 high-altitude hyperuricemia cell injury model was established to verify the therapeutic mechanism of DIO in rats with high-altitude hyperuricemia. Western blot was used to detect the expression of related proteins in renal tissues and cell models. The results showed that DIO and its active metabolite DG regulate renal lipid metabolism through the EPHX2 gene, attenuate renal inflammatory reaction, and then promote the excretion of uric acid and reduce its reabsorption, which ultimately achieves the effect of treating plateau hyperuricemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
- Beijing Institute of Radiation Medicine, Beijing 100859, China.
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China.
ORCID-Profile: Cheng Zhang
Förderung
- yue Gao
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
Zitieren
APA
Dang, W., Li, F., Gao, R., Zhang, C., Cheng, H., Wu, Z., Yang, T., Pan, J., Tang, X., & Gao, Y. (2024). Protective Effects of Dioscin and Diosgenin on Plateau Hyperuricemia by Attenuating Renal Inflammation via EPHX2. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413399
Vancouver
Dang W, Li F, Gao R, Zhang C, Cheng H, Wu Z, et al. Protective Effects of Dioscin and Diosgenin on Plateau Hyperuricemia by Attenuating Renal Inflammation via EPHX2. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413399
BibTeX
@article{Dang2024,
author = {Dang, Wanyun and Li, Fangyang and Gao, Rong and Zhang, Cheng and Cheng, Hongbo and Wu, Zhenhui and Yang, Tingyu and Pan, Jinchao and Tang, Xianglin and Gao, Yue},
title = {Protective Effects of Dioscin and Diosgenin on Plateau Hyperuricemia by Attenuating Renal Inflammation via EPHX2},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413399}
}
EUVIMED